Objectives: An increased platelet activation status is present in patients with preeclampsia.
2
An apparent decreased concentration was observed early in pregnancy in future preeclampsia.
3
Mechanisms by which preeclampsia affects cerebrovascular structure and function require additional study.
4
High-altitude residence during pregnancy is associated with an increased incidence of preeclampsia.
5
Adverse outcomes were highest in women with severe pregnancy-associated hypertension or preeclampsia.
1
The early detection of pre-eclampsia is a major challenge in obstetric care.
2
Hypertension, one indicator of pre-eclampsia, is more common in all expectant mothers.
3
Turbidity measurements and SEM revealed dense fibrin structure in patients with pre-eclampsia.
4
During her last pregnancy, Michelle was diagnosed with pre-eclampsia, or pregnancy-induced hypertension.
5
A case of severe ECG abnormalities occurring during pre-eclampsia is presented.
1
However, long-term data are lacking among women with gestationalhypertension without proteinuria.
2
Maternal adverse pregnancy outcomes were pre-eclampsia, gestational diabetes, and gestationalhypertension.
3
We ascertained gestationalhypertension, pre-eclampsia, gestational diabetes and preterm birth diagnoses from medical records.
4
Patients: A total of 65 women with gestationalhypertension at 24-26 weeks.
5
When looking at gestationalhypertension and pre-eclampsia as outcomes, (multiple) logistic regression was used in the analysis.
1
The results were adjusted for maternal age, gestational age and pregnancy-inducedhypertension.
2
During her last pregnancy, Michelle was diagnosed with pre-eclampsia, or pregnancy-inducedhypertension.
3
Group 1 patients had a significantly higher incidence of pregnancy-inducedhypertension and preterm birth.
4
Of all the interaction terms, only the bromocriptine by pregnancy-inducedhypertension interaction was significant.
5
Incidence of pregnancy-inducedhypertension or preeclampsia, gestational week at delivery and birthweight were recorded.
1
Methods: Secondary analysis of a randomized multicenter trial of antioxidant supplementation versus placebo in nulliparous low-risk women to prevent pregnancyassociatedhypertension.